药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Metocurine
Temafloxacin
The therapeutic efficacy of Empagliflozin can be increased when used in combination with Temafloxacin.
Metocurine
Nicorandil
Nicorandil may increase the hypotensive activities of Empagliflozin.
Metocurine
Aripiprazole lauroxil
Aripiprazole lauroxil may increase the hypotensive activities of Empagliflozin.
Metocurine
Cilazaprilat
The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Empagliflozin is combined with Cilazaprilat.
Metocurine
Quinoline Yellow WS
The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Empagliflozin is combined with Quinoline Yellow WS.
Metocurine
Moexiprilat
The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Empagliflozin is combined with Moexiprilat.
Metocurine
Trandolaprilat
The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Empagliflozin is combined with Trandolaprilat.
Metocurine
Quinaprilat
The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Empagliflozin is combined with Quinaprilat.
Metocurine
Perindoprilat
The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Empagliflozin is combined with Perindoprilat.
Metocurine
Ramiprilat
The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Empagliflozin is combined with Ramiprilat.
Metocurine
Fosinoprilat
The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Empagliflozin is combined with Fosinoprilat.
Metocurine
Benazeprilat
The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Empagliflozin is combined with Benazeprilat.
Metocurine
Delapril
The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Empagliflozin is combined with Delapril.
Metocurine
Zofenopril
The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Empagliflozin is combined with Zofenopril.
Metocurine
Imidapril
The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Empagliflozin is combined with Imidapril.
Metocurine
Enalaprilat
The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Empagliflozin is combined with Enalaprilat.
Cefoxitin
Relugolix
The serum concentration of Relugolix can be increased when it is combined with Suvorexant.
Cefoxitin
Berotralstat
The serum concentration of Berotralstat can be increased when it is combined with Suvorexant.
Cefoxitin
Pralsetinib
The serum concentration of Pralsetinib can be increased when it is combined with Suvorexant.
Cefoxitin
Satralizumab
The serum concentration of Suvorexant can be decreased when it is combined with Satralizumab.